Xiangming Hu1,2, Deyi Huang2, Caidi Lin2, Xiaoming Li2, Fen Lu2, Wenting Wei2, Zhihong Yu2, Huosheng Liao2, Fang Huang2, Xuezhen Huang2, Fujun Jia3,4. 1. The Second School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, Guangdong Province, China. 2. Department of Comprehensive Medicine, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, Guangdong Province, China. 3. The Second School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, Guangdong Province, China. jiafujun@126.com. 4. Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangdong Mental Health Center, No. 123, Huifu Road, Yuexiu District, Guangzhou, 510080, Guangdong Province, China. jiafujun@126.com.
Abstract
PURPOSE: The objective of this study was to investigate the efficacy of zolpidem for improving post-operative sleep quality among patients with infective endocarditis (IE) and to identify the potential risk factors for impaired sleep quality at 6 months after surgery. METHODS: Patients with IE who underwent surgical treatment were divided into two groups according to zolpidem usage. The Pittsburgh Sleep Quality Index (PSQI) and Epworth Sleepiness Scale (ESS) were used to evaluate patients' sleep quality and daytime sleepiness at baseline, which was the second day after transferal, and at 6 months after surgery. Logistic regression was used to identify potential risk factors. RESULTS: There were 32 patients in the zolpidem group and 42 in the control group. The PSQI and ESS scores at 6 months after surgery were significantly lower than those at baseline in both groups (P = 0.04). Additionally, 9 patients (28%) in the zolpidem group and 22 patients (52%) in the control group suffered poor sleep quality. Multivariate analysis identified age (odds ratio [OR] = 1.26, 95% confidence interval [CI]: 1.12-1.42), baseline PSQI score (OR = 2.66, 95%CI: 1.55-4.65), and no zolpidem usage (OR = 45.48, 95%CI: 3.01-691.23) as independent factors for poor sleep quality. CONCLUSIONS: Poor sleep quality after IE surgery was prevalent among patients even 6 months after IE surgery. Age, baseline PSQI score and no zolpidem usage were independently associated with poor sleep quality. Therefore, zolpidem has the potential to be an effective part of a treatment arsenal for poor sleep quality after surgical treatment for IE.
PURPOSE: The objective of this study was to investigate the efficacy of zolpidem for improving post-operative sleep quality among patients with infective endocarditis (IE) and to identify the potential risk factors for impaired sleep quality at 6 months after surgery. METHODS: Patients with IE who underwent surgical treatment were divided into two groups according to zolpidem usage. The Pittsburgh Sleep Quality Index (PSQI) and Epworth Sleepiness Scale (ESS) were used to evaluate patients' sleep quality and daytime sleepiness at baseline, which was the second day after transferal, and at 6 months after surgery. Logistic regression was used to identify potential risk factors. RESULTS: There were 32 patients in the zolpidem group and 42 in the control group. The PSQI and ESS scores at 6 months after surgery were significantly lower than those at baseline in both groups (P = 0.04). Additionally, 9 patients (28%) in the zolpidem group and 22 patients (52%) in the control group suffered poor sleep quality. Multivariate analysis identified age (odds ratio [OR] = 1.26, 95% confidence interval [CI]: 1.12-1.42), baseline PSQI score (OR = 2.66, 95%CI: 1.55-4.65), and no zolpidem usage (OR = 45.48, 95%CI: 3.01-691.23) as independent factors for poor sleep quality. CONCLUSIONS: Poor sleep quality after IE surgery was prevalent among patients even 6 months after IE surgery. Age, baseline PSQI score and no zolpidem usage were independently associated with poor sleep quality. Therefore, zolpidem has the potential to be an effective part of a treatment arsenal for poor sleep quality after surgical treatment for IE.
Authors: Feng-Rong An; Yun-Ke Qi; Jiao-Ying Zeng; Yan-Ming Ding; Helen F K Chiu; Gabor S Ungvari; Robin Newhouse; Doris S F Yu; Kelly Y C Lai; Yu-Tao Xiang Journal: Perspect Psychiatr Care Date: 2015-01-30 Impact factor: 2.186
Authors: David R Murdoch; G Ralph Corey; Bruno Hoen; José M Miró; Vance G Fowler; Arnold S Bayer; Adolf W Karchmer; Lars Olaison; Paul A Pappas; Philippe Moreillon; Stephen T Chambers; Vivian H Chu; Vicenç Falcó; David J Holland; Philip Jones; John L Klein; Nigel J Raymond; Kerry M Read; Marie Francoise Tripodi; Riccardo Utili; Andrew Wang; Christopher W Woods; Christopher H Cabell Journal: Arch Intern Med Date: 2009-03-09
Authors: Juan Gálvez-Acebal; Manuel Almendro-Delia; Josefa Ruiz; Arístides de Alarcón; Francisco J Martínez-Marcos; José M Reguera; Radka Ivanova-Georgieva; Mariam Noureddine; Antonio Plata; José M Lomas; Javier de la Torre-Lima; Carmen Hidalgo-Tenorio; Rafael Luque; Jesús Rodríguez-Baño Journal: Mayo Clin Proc Date: 2014-08-30 Impact factor: 7.616
Authors: L Alagna; L P Park; B P Nicholson; A J Keiger; J Strahilevitz; A Morris; D Wray; D Gordon; F Delahaye; J Edathodu; J M Miró; N Fernández-Hidalgo; F M Nacinovich; R Shahid; C W Woods; M J Joyce; D J Sexton; V H Chu Journal: Clin Microbiol Infect Date: 2013-11-11 Impact factor: 8.067
Authors: Mahbub Jamil; Ibrahim Sultan; Thomas G Gleason; Forozan Navid; Michael A Fallert; Matthew S Suffoletto; Arman Kilic Journal: J Thorac Dis Date: 2019-11 Impact factor: 2.895
Authors: Xiao-Lan Cao; Shi-Bin Wang; Bao-Liang Zhong; Ling Zhang; Gabor S Ungvari; Chee H Ng; Lu Li; Helen F K Chiu; Grace K I Lok; Jian-Ping Lu; Fu-Jun Jia; Yu-Tao Xiang Journal: PLoS One Date: 2017-02-24 Impact factor: 3.240
Authors: Leandro Slipczuk; J Nicolas Codolosa; Carlos D Davila; Abel Romero-Corral; Jeong Yun; Gregg S Pressman; Vincent M Figueredo Journal: PLoS One Date: 2013-12-09 Impact factor: 3.240